Urgent.News

the world's headlines, one feed

Health & Medicine

GLP-1 drug linked to heart benefits for high-risk patients

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today.

GLP-1 drug linked to heart benefits for high-risk patients

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine